HOME >> BIOLOGY >> NEWS
Acamprosate: potential medication for treating alcoholism

  • Acamprosate is a medication used in Europe and elsewhere to prevent relapse in alcoholics.
  • New findings, in conjunction with previous research, indicate that acamprosate should be safe to take when people are drinking, and should not make them want to drink more or behave differently over and above the effects of alcohol alone.

As scientists and clinicians learn more about the changes in brain chemistry that chronic alcohol use can cause, the pharmacotherapy of alcoholism has become increasingly relevant for the treatment of alcohol craving, abstinence, and relapse. A study in the July issue of Alcoholism: Clinical & Experimental Research examines the effects of acamprosate (calcium acetyl homotaurinate), a medication used in Europe and elsewhere to prevent relapse in alcoholics, and currently under review for use by the U.S. Food and Drug Administration. The study's findings, in conjunction with previous research, indicate that acamprosate should be safe to take when people are drinking, and should not make them want to drink more or behave differently over and above the effects of alcohol alone.

"To our knowledge, this is the first published report that examines potential interactions between acamprosate and alcohol in humans," said Elisabeth J. Houtsmuller, assistant professor of behavioral biology at Johns Hopkins University School of Medicine and corresponding author for the study. "Other studies have shown that acamprosate helps people abstain from drinking, and our study examined what may underlie this. Because acamprosate acts on a neurotransmitter system the glutamate system that alcohol also has many effects on, we thought it was possible that acamprosate might change some of alcohol's effects, and this might be part of why it helps people to abstain. We therefore examined whether acamprosate alters the way alcohol makes people feel."

The findings suggest that acamprosate does not'"/>


14-Jul-2004


Page: 1 2 3 4

Related biology news :

1. Award winning researchers reveal potential new role for Glivec
2. Evidence builds for potential new cancer drug target
3. Scientists discover potential new way to control drug-resistant bacteria
4. Tiny molecules have big potential as cancer drugs, Stanford researcher believes
5. OneWorld Health compiles comprehensive state of infectious diarrhea treatments, potential solutions
6. Managing occupational exposures to potential bioterrorist agents
7. Location of potential familial lung cancer gene discovered
8. Common chemicals morphing into potential toxins in Arctic
9. Yale researchers discover new potential asthma therapeutic targets related to parasites and insects
10. Researchers identify two potential protein targets for new drug therapies for pancreatic cancer
11. New screening method turns up potential compound for treating anthrax

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/27/2018)... , ... November 27, 2018 , ... ... cryogenics industry a sealing solution with a broader range of usage temperature compared ... PEEK expert will introduce its new VICTREX CT™ 200 for dynamic sealing applications ...
(Date:11/23/2018)... FRANCISCO (PRWEB) , ... November 23, 2018 , ... ... of Dr. Emeran Mayer, MD, Executive Director of the G. Oppenheimer Center for ... of leading scientists and doctors from around the world, Dr. Mayer will bring ...
(Date:11/20/2018)... ... November 19, 2018 , ... ... Bay Area -- the first and only non-invasive buttock lift procedure, with no ... cleared to strengthen, tone and firm the buttocks to provide a safe and ...
Breaking Biology News(10 mins):
(Date:11/9/2018)... ... November 08, 2018 , ... ... States, adopted a machine-learning powered approach to increasing recovery rates by creating a ... Artificially Intelligent Collections (AIC) product developed by NLP Logix, a Jacksonville, Florida-based AI ...
(Date:11/6/2018)... (PRWEB) , ... November 06, 2018 , ... ... mobile app for clinical trial data collection and management. TrialKit ™, an ... with compatible generation devices can quickly and easily sign in to the app ...
(Date:11/5/2018)... ... November 05, 2018 , ... 2Blades has completed a non-exclusive ... effector code technology for applications in advancing research in epigenetic technology. , ... discovery in 2009, the efficacy of TAL effector-based DNA targeting has been established ...
(Date:10/31/2018)... ... 2018 , ... Myoscience, Inc. announced today that it has ... Tennessee. This study enrolled 125 patients and compares the effect of cryoanalgesia ... total knee replacement surgery (TKA). , The Myoscience iovera° system is currently being ...
Breaking Biology Technology:
Cached News: